New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial
Cancer Patients Who Die In Hospital Or ICU Have Worse QOL; Caregivers Affected, Too
Rituximab Prolonged Survival Of CLL In Phase III Study
A Low-Cost Vaccine To Enter Clinical Trials In A Year
HPV DNA Testing Reduced Cervical Cancer Precursors
Targeting Men At High Risk Finds More Head & Neck Cancer
Half Of Mexican-Origin Women With Breast Cancer Diagnosed Before Age 50, Study Finds
Multivitamin Use Doesn’t Impact Outcomes, Study Finds
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- Ross Levine named chief scientific officer of Memorial Sloan Kettering Cancer Center
- Study finds no correlation between cancer burden in catchment areas and cancer centers’ CCSG funding
- How animal testing became a MAHA political wedge issue
While cancer scientists say NIH, FDA moves are premature, animal rights advocates say changes aren’t drastic enough - Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research
- Latinx oncology leaders talk about the impact of federal policy on cancer outcomes in Latinx communities
- Why both somatic and germline genomic profiling are essential for precision oncology